In this On-Demand webinar, we explore the recently released MAPS Standards & Guidance (S+G) documents, “Measuring Value and Impact in Medical Affairs” and “Strategic Medical Planning Guide.”
Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
Share of Voice used to be a numbers game to increase sales and market share. But with the advent of the digital age, Share of Voice has come to mean more than just numbers.
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
In this interview recorded at MAPS 2022 Global with Lobna Salem we discuss building a Medical Affairs department from the ground up.
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.